Liao, David SGrossi, Federico VEl Mehdi, DelphineGerber, Monica RBrown, David MHeier, Jeffrey SWykoff, Charles CSingerman, Lawrence JAbraham, PremaGrassmann, FelixNuernberg, PeterWeber, Bernhard H FDeschatelets, PascalKim, Robert YChung, Carol YRibeiro, Ramiro MHamdani, MohamedRosenfeld, Philip JBoyer, David SSlakter, Jason SFrancois, Cedric G2020-06-182020-06-182020-02Liao, D S, Grossi, F V, El Mehdi, D, Gerber, M R, Brown, D M, Heier, J S, Wykoff, C C, Singerman, L J, Abraham, P, Grassmann, F, Nuernberg, P, Weber, B H F, Deschatelets, P, Kim, R Y, Chung, C Y, Ribeiro, R M, Hamdani, M, Rosenfeld, P J, Boyer, D S, Slakter, J S & Francois, C G 2020, 'Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration : A Randomized Phase 2 Trial', Ophthalmology, vol. 127, no. 2, pp. 186-195. https://doi.org/10.1016/j.ophtha.2019.07.0110161-6420ORCID: /0000-0003-1390-7528/work/76211716https://hdl.handle.net/2164/14537Copyright © 2019 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.101366159engABNORMALITIESCHOROIDAL NEOVASCULARIZATIONECULIZUMABEYE DISEASEFEATURESINFLAMMATIONMACROPHAGE POLARIZATIONPLASTICITYRANIBIZUMAB TREATMENTVISION-RELATED FUNCTIONR MedicineOphthalmologyRJournal article10.1016/j.ophtha.2019.07.011http://www.scopus.com/inward/record.url?scp=85071397913&partnerID=8YFLogxK1272